A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer

被引:0
|
作者
Ava Kwong
L. P. Wong
H. N. Wong
F. B. F. Law
E. K. O. Ng
Y. H. Tang
W. K. Chan
L. S. Ho
K. H. Kwan
M. Poon
T. T. Wong
F. C. S. Leung
S. W. W. Chan
M. W. L. Ying
E. S. K. Ma
J. M. Ford
机构
[1] The University of Hong Kong,Division of Breast Surgery, Queen Mary and Tung Wah Hospital
[2] Hong Kong Sanatorium and Hospital,Department of Molecular Pathology
[3] Hong Kong Sanatorium and Hospital,Department of Pathology
[4] Hong Kong Sanatorium and Hospital,Department of Surgery
[5] Princess Margaret Hospital,The Hong Kong Hereditary and High Risk Breast Cancer Programme
[6] Tuen Mun Hospital,undefined
[7] Queen Elizabeth Hospital,undefined
[8] Pamela Youde Nethersole Hospital,undefined
[9] United Christian Hospital,undefined
[10] Kwong Wah Hospital,undefined
[11] Stanford University School of Medicine,undefined
[12] The Hong Kong Hereditary Breast Cancer Family Registry,undefined
来源
关键词
BRCA Mutation; Male Breast Cancer; Recurrent Mutation; Male Breast Cancer Patient; Deleterious BRCA;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:683 / 686
页数:3
相关论文
共 50 条
  • [21] BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer
    Ruth Gershoni-Baruch
    Efrat Dagan
    Getta Fried
    Ilana Kepten
    Eliezer Robinson
    European Journal of Human Genetics, 1999, 7 : 833 - 836
  • [22] BRCA2 founder mutation in Slovenian breast cancer families
    Mateja Krajc
    Jacques De Grève
    Guido Goelen
    Erik Teugels
    European Journal of Human Genetics, 2002, 10 : 879 - 882
  • [23] BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer
    Gershoni-Baruch, R
    Dagan, E
    Fried, G
    Kepten, I
    Robinson, E
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1999, 7 (07) : 833 - 836
  • [24] The prevalence of BRCA1 and BRCA2 mutations in Chinese women with breast cancer.
    Hu, Z.
    Li, W-F
    Song, C-G
    Shen, Z-Z
    Huang, W.
    Shao, Z-M
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S250 - S250
  • [25] Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer
    Hodgson, SV
    Heap, E
    Cameron, J
    Ellis, D
    Mathew, CG
    Eeles, RA
    Solomon, E
    Lewis, CM
    JOURNAL OF MEDICAL GENETICS, 1999, 36 (05) : 369 - 373
  • [26] The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer
    Song, Chuan-Gui
    Hu, Zhen
    Wu, Jiong
    Luo, Jian-Min
    Shen, Zhen-Zhou
    Huang, Wei
    Shao, Zhi-Ming
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (10) : 617 - 626
  • [27] The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer
    Chuan-Gui Song
    Zhen Hu
    Jiong Wu
    Jian-Min Luo
    Zhen-Zhou Shen
    Wei Huang
    Zhi-Ming Shao
    Journal of Cancer Research and Clinical Oncology, 2006, 132 : 617 - 626
  • [28] Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer
    Chappuis, PO
    Hamel, N
    Paradis, AJ
    Deschênes, J
    Robidoux, A
    Potvin, C
    Cantin, J
    Tonin, P
    Ghadirian, P
    Foulkes, WD
    CLINICAL GENETICS, 2001, 59 (06) : 418 - 423
  • [29] The founder mutations in the BRCA1, BRCA2, and ATM genes in Moroccan Jewish women with breast cancer
    Kreiss, Y
    Barak, F
    Baruch, RG
    Levy-Lahad, E
    Pras, E
    Friedman, E
    GENETIC TESTING, 2000, 4 (04): : 403 - 407
  • [30] High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients
    Al-Joharah Alhuqail
    Areej Alzahrani
    Hannah Almubarak
    Sarah Al-Qadheeb
    Lamyaa Alghofaili
    Nisreen Almoghrabi
    Hamed Alhussaini
    Ben Ho Park
    Dilek Colak
    Bedri Karakas
    Breast Cancer Research and Treatment, 2018, 168 : 695 - 702